Share prices for medtech companies grew drastically in 2014.  An article via explains that “Large companies saw their share prices grow, with Covidien’s share price growing the most. Even as the Irish company bid goodbye to the markets as a standalone company prior to the consummation of the deal with Medtronic, it saw its share price grow the most—53%—out of large-cap medtech companies.”  Here are the big market movers who saw millions added to their market cap and millions taken away: